Skip to main content
Print Save

MYLAN 7160 MYLAN 7160 Pill - purple capsule/oblong

Pill with imprint MYLAN 7160 MYLAN 7160 is Purple, Capsule/Oblong and has been identified as Celecoxib 100 mg. It is supplied by Mylan Institutional Inc.

Celecoxib is used in the treatment of Ankylosing Spondylitis; Osteoarthritis; Familial Adenomatous Polyposis; Juvenile Rheumatoid Arthritis; Headache and belongs to the drug class cox-2 inhibitors. prior to 30 weeks gestation: Risk cannot be ruled out during pregnancy. starting at 30 weeks gestation: There is positive evidence of human fetal risk during pregnancy. Celecoxib 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for MYLAN 7160 MYLAN 7160

Celecoxib 100 mg MYLAN 7160 MYLAN 7160
Celecoxib 100 mg MYLAN 7160 MYLAN 7160
Celecoxib 100 mg MYLAN 7160 MYLAN 7160

Celecoxib

Imprint
MYLAN 7160 MYLAN 7160
Strength
100 mg
Color
Purple
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
Cox-2 inhibitors
Pregnancy Category
C - Risk cannot be ruled out - prior to 30 weeks gestation, D - Positive evidence of risk - starting at 30 weeks gestation
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Institutional Inc.
Inactive Ingredients
silicon dioxide, croscarmellose sodium, lactose monohydrate, magnesium stearate, sodium lauryl sulfate, titanium dioxide, D&C Red No. 28, FD&C Blue No. 1, ferrosoferric oxide, D&C Yellow No. 10, FD&C Blue No. 2, FD&C Red No. 40, propylene glycol, shellac

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
51079-0199 (Discontinued) UDL Laboratories Inc.
00378-7160 (Discontinued) Mylan Pharmaceuticals Inc.
Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer